NIMODIPINE for Cerebral vasoconstriction: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 50 adverse event reports in the FDA FAERS database where NIMODIPINE was used for Cerebral vasoconstriction.
Most Reported Side Effects for NIMODIPINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 37 | 8.9% | 4 | 8 |
| Hypotension | 37 | 8.9% | 2 | 26 |
| Cholestasis | 31 | 7.5% | 0 | 14 |
| Off label use | 28 | 6.7% | 0 | 4 |
| Intentional overdose | 26 | 6.3% | 0 | 26 |
| Cardiogenic shock | 25 | 6.0% | 0 | 25 |
| Toxicity to various agents | 25 | 6.0% | 3 | 21 |
| Renal failure | 24 | 5.8% | 0 | 24 |
| Premature baby | 23 | 5.5% | 0 | 6 |
| Brain injury | 22 | 5.3% | 0 | 22 |
| Cognitive disorder | 22 | 5.3% | 0 | 22 |
| Foetal exposure during pregnancy | 22 | 5.3% | 0 | 5 |
| Lactic acidosis | 22 | 5.3% | 0 | 22 |
| Sinus bradycardia | 21 | 5.1% | 0 | 21 |
| Cerebral ischaemia | 20 | 4.8% | 1 | 19 |
Other Indications for NIMODIPINE
Product used for unknown indication (131)
Subarachnoid haemorrhage (39)
Reversible cerebral vasoconstriction syndrome (26)
Haemorrhage intracranial (20)
Hypertension (16)
Headache (13)
Intentional overdose (10)
Prophylaxis (10)
Intracranial pressure increased (7)
Vasospasm (6)